Associated Papers
Comparative analysis of RNA expression in a single institution cohort of pediatric cancer patients.
Vasquez YA et al.
Npj Precision Oncology, 2025
40119139 (PubMed )
Supplement: 41698_2025_852_MOESM11_ESM.xlsx › Supplementary_Data_9
Molecular and Functional Key Features and Oncogenic Drivers in Thymic Carcinomas.
Barachini S et al.
Cancers, 2023
Plasma Sequencing for Patients with GIST-Limitations and Opportunities in an Academic Setting.
Falkenhorst J et al.
Cancers, 2022
36428589 (PubMed )
Supplement: cancers-14-05496-s001.zip › cancers-1969013-supplementary.pdf
Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in KIT, ERBB2, KRAS, and TP53 in 30% of Thymic Carcinomas.
Szpechcinski A et al.
Cancers, 2022
35884448 (PubMed )
Supplement: cancers-14-03388-s001.zip › Szpechcinski_Szolkowska_-_NGS_analysis_of_53_thymic_epithelial_tumors_-_Table_S3.pdf
Mutation analysis of the EGFR gene and its downstream signaling pathway in thymic carcinoma patients from a Chinese Han population.
Zhan P et al.
The Clinical Respiratory Journal, 2018
Stabilization of disease after targeted therapy in a thymic carcinoma with KIT mutation detected by clinical next-generation sequencing.
Hagemann IS et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 2014
When a thymic carcinoma "becomes" a GIST.
Rossi V et al.
Lung Cancer (amsterdam, Netherlands), 2013
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
Schirosi L et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2012
Reappraisal of KIT mutation in adenoid cystic carcinomas of the salivary gland.
Sung JY et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2012
Select a paper to view details